Atlas Trials

Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis

Clinical trial NCT05554302 · RECRUITING

Trial details

NCT number
NCT05554302
Sponsor
Baptist Health South Florida
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Brain MetastasesBrain Cancer
Start date
2023-01-10
Primary completion
2030-01-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.